ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.
Registry-linked trialAbstract readEditorial
In one paragraph
Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05525832 (Effect of Nasopharyngeal Wash With Normal Saline on SARS-CoV2 Viral Load), which is not on this map. Cited by 103 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effect of Nasopharyngeal Wash With Normal Saline on SARS-CoV2 Viral Load: A Randomized Controlled Trial
Who cites it
103 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Attitudes of COVID-19 vaccination among college students: A systematic review and meta-analysis of willingness, associated determinants, and reasons for hesitancy.Human vaccines & immunotherapeutics · 2022Pooled it
- Nasopharyngeal Wash with Normal Saline Decreases SARS-CoV-2 Viral Load: A Randomized Pilot Controlled Trial.Canadian respiratory journal · 2022Trial
- Broadly neutralizing monoclonal antibodies derived from mRNA LNP immunization exhibit potent neutralizing ability against JN.1, KP.3.1.1 and XEC new Omicron variants.The Journal of general virology · 2026Article
- Impaired neutralizing antibody responses against the BA1.1, BA.2, and BA.5 Omicron SARS-CoV-2 subvariants in hospitalized adults infected with pre-Omicron variants in Argentina.Microbiology spectrum · 2026Article
- Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in Sub-Saharan Africa: Longitudinal Trend Analysis.JMIR public health and surveillance · 2024Article
- Highly sensitive wastewater surveillance of SARS-CoV-2 variants by targeted next-generation amplicon sequencing provides early warning of incursion in Victoria, Australia.Applied and environmental microbiology · 2024Article
- The role of hematological parameters in asymptomatic and non-severe cases of Omicron variant infection.Virology journal · 2024Article
- Replication kinetics and infectivity of SARS-CoV-2 Omicron variant sublineages recovered in the Republic of Korea.Osong public health and research perspectives · 2024Article
- Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.Journal of virology · 2024Article
- SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epithelia.Cell reports · 2024Article
- Prioritizing post-COVID-19 health research in sub-Saharan Africa: A modified Delphi study for future pandemic.Scientific African · 2024Article
- Genomic Surveillance of SARS-CoV-2: Data Analysis and Assessment of Tunisian Strategy from January 2021 to February 2022.Epidemiologia (Basel, Switzerland) · 2024Article
- In silico analysis of balsaminol as anti-viral agents targeting SARS-CoV-2 main protease, spike receptor binding domain and papain-like protease receptors.In silico pharmacology · 2024Article
- Variation and evolution analysis of SARS-CoV-2 using self-game sequence optimization.Frontiers in microbiology · 2024Article
- Characteristics of SARS-CoV-2 Omicron BA.5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysis.Frontiers in microbiology · 2024Article
- Regulatory variants of APOBEC3 genes potentially associate with COVID-19 severity in populations with African ancestry.Scientific reports · 2023Article
- Nucleocapsid single point-mutation associated with drop-out on RT-PCR assay for SARS-CoV-2 detection.BMC infectious diseases · 2023Article
- SARS-CoV-2 Omicron BA.5.2-infection and COVID-19 in persons with chronic myeloid leukaemia.Journal of cancer research and clinical oncology · 2023Article
- Mycobacterium tuberculosis and its clever approaches to escape the deadly macrophage.World journal of microbiology & biotechnology · 2023Review
- A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences.Human vaccines & immunotherapeutics · 2023Article
43 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
44 authors.
Eskild PetersenEuropean Society for Clinical Microbiology and Infectious Diseases, Emerging Infections Task Force, ESCMID, Basel, Switzerland; Institute for Clinical Medicine, Aarhus University, Denmark; European Travel Medicine Network, Méditerranée Infection Foundation, Marseille, France. Electronic address: eskild.petersen@gmail.com.
Francine NtoumiFondation Congolaise pour la Recherche Médicale (FCRM), Brazzaville, Republic of Congo; Institute for Tropical Medicine, University of Tübingen, Germany. Electronic address: fntoumi@fcrm-congo.com.
David S HuiDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong. Electronic address: dschui@cuhk.edu.hk.
Aisha AbubakarAhmadu Bello University, Zaria, Nigeria. Electronic address: draishau@yahoo.com.
Laura D KramerSchool of Public Health, State University at Albany, Albany, New York, USA. Electronic address: laura.kramer@health.ny.gov.
Christina ObieroInternational Society for Infectious Diseases, Boston, United States; Clinical Research Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya; Depart of Global Health, University of Amsterdam, Amsterdam, Noord-Holland, The Netherlands. Electronic address: christinaobiero@gmail.com.
Paul Anantharajah TambyahInternational Society for Infectious Diseases, Boston, United States; Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: mdcpat@nus.edu.sg.
Lucille BlumbergDivision of Public Health Surveillance and Response, National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg South Africa. Electronic address: lucilleb@nicd.ac.za.
Richard YapiInternational Society for Infectious Diseases, Boston, United States; Centre d'Entomologie Médicale et Vétérinaire, CEMV - Université Alassane Ouattara, Bouaké, Côte d'Ivoire. Electronic address: richard.yapi@csrs.ci.
Seif Al-AbriInternational Society for Infectious Diseases, Boston, United States; Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman. Electronic address: salabri@gmail.com.
Tatiana de Castro Abreu PintoInternational Society for Infectious Diseases, Boston, United States; Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Brazil. Electronic address: tcap@micro.ufrj.br.
Dorothy Yeboah-ManuNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana. Electronic address: Dyeboah-Manu@noguchi.ug.edu.gh.
Najmul HaiderPathobiology and Population Science, The Royal Veterinary College, London, United Kingdom. Electronic address: nhaider@rvc.ac.uk.
Danny AsogunCommunity Medicine, Irrua Specialist Teaching Hospital, Irrua, Edo, Nigeria. Electronic address: dannyasogun38@gmail.com.
Thirumalaisamy P VelavanInstitute of Tropical Medicine, University of Tübingen, Tübingen, Germany; and Vietnamese-German Center of Medical Research, Hanoi, Vietnam. Electronic address: velavan@medizin.uni-tuebingen.de.
Nathan KapataNational Public Health Institute, Ministry of Health, and UNZA-UCLMS Research and Training Program, Lusaka, Zambia. Electronic address: nkapata@gmail.com.
Matthew BatesHerpeZ and UNZA-UCLMS Project, University Teaching Hospital, Lusaka, Zambia; and School of Life Sciences, University of Lincoln, Lincoln, UK. Electronic address: MBates@lincoln.ac.uk.
Rashid AnsumanaMercy Hospital Research Laboratory, Bo, Freetown, Sierra Leone. Electronic address: rashidansumana@gmail.com.
Chiara MontaldoNational Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Rome, Italy. Electronic address: chiara.montaldo@inmi.it.
Luchenga Mucheleng'angaMinistry of Home Affairs, Office of the State Forensic Pathologist, and UNZA-UCLMS Research and Training Program, University Teaching Hospital, Lusaka, Zambia. Electronic address: luchengam@gmail.com.
John TemboHERPEZ and UNZA-UCLMS Research and Training Program, University Teaching Hospital, Lusaka, Zambia. Electronic address: john.tembo@gmail.com.
Peter MwabaLusaka Apex Medical University, Faculty of Medicine, and UNZA-UCLMS Research and Training Project, Lusaka, Zambia. Electronic address: pbmwaba2000@gmail.com.
Cordelia M HimwazeUniversity Teaching Hospital, Department of Pathology and Microbiology; and UNZA-UCLMS Research and Training Program, University Teaching Hospital, Lusaka, Zambia. Electronic address: cordeliahimwaze@gmail.com.
Muzamil Mahdi Abdel HamidDepartment of Parasitology and Medical Entomology, Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan. Electronic address: mahdi@iend.org.
Sayoki MfinangaMuhimbili Medical Research Centre National Institute for Medical Research, Dar es Salaam, Tanzania. Electronic address: gsmfinanga@yahoo.com.
Leonard MboeraSACIDS Foundation for One Health, Sokoine, University of Agriculture, Morogoro, Tanzania. Electronic address: lmboera@nimr.or.tz.
Tajudeen RajDivision of Public Health Institutes and Research, Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia. Electronic address: TajudeenR@africa-union.org.
Eleni AklilluDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital-Huddinge, Karolinska Institute, Stockholm, Sweden. Electronic address: Eleni.Aklillu@ki.se.
Francisco VeasMolecular Comparative Immuno-Physiopathology Lab), Joint Research Unit-Ministry of Defense, Faculty of Pharmacy, French Research Institute for Development (IRD), Montpellier University, Montpellier, France. Electronic address: francisco.veas@ird.fr.
Sarah EdwardsEthics and Governance, University College London, London, United Kingdom. Electronic address: sarah.edwards@ucl.ac.uk.
Pontiano KaleebuMedical Research Council/Uganda Virus Research Institute, Entebbe, Uganda. Electronic address: pontiano.kaleebu@mrcuganda.org.
Timothy D McHughCenter for Clinical Microbiology, Division of Infection and Immunity, University College London, London, United Kingdom. Electronic address: t.mchugh@ucl.ac.uk.
Jeremiah ChakayaDepartment of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya. Electronic address: chakaya.jm@gmail.com.
Thomas NyirendaEuropean and Developing Countries clinical trials Partnership, EDCTP Africa Office, Cape Town, South Africa. Electronic address: nyirenda@edctp.org.
Moses BockarieEuropean and Developing Countries clinical trials Partnership, EDCTP Africa Office, Cape Town, South Africa. Electronic address: bockarie@edctp.org.
Peter S NyasuluDivision of Epidemiology & Biostatistics, Faculty of Medicine; Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: pnyasulu@sun.ac.za.
Christian WejseDepartment of Infectious Diseases, Institute of Publich Health, Aarhus University Hospital, Skejby, Denmark. Electronic address: wejse@ph.au.dk.
Jean-Jacques Muyembe-TamfumNational Institute of Biomedical Research and Department of Medical Microbiology and Virology, Faculty of Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo. Electronic address: jjmuyembet@gmail.com.
Esam I AzharSpecial Infectious Agents Unit-BSL3, King Fahd Medical Research Center, King Abdulaziz University; Dept. of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: eazhar@kau.edu.sa.
Markus MaeurerImmunoSurgery Unit, Champalimaud Centre for the Unknown, Lisbon, Portugal; Medizinische Klinik, Johannes Gutenberg University Mainz, Germany. Electronic address: markus.maeurer@fundacaochampalimaud.pt.
Jean B NachegaDepartment of Medicine and Division of Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa, and Depts of Epidemiology, Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA. Electronic address: jbn16@pitt.edu.
Richard KockThe Royal Veterinary College, University of London, Hawkshead Lane, North Mymms, Hatfield, UK. Electronic address: rkock@rvc.ac.uk.
Giuseppe IppolitoGeneral Directorate for Research and Innovation in Health, Ministry of Health, Rome, Italy. Electronic address: g.ippolito@sanita.it.
Alimuddin ZumlaCenter for Clinical Microbiology, Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom. Electronic address: a.zumla@ucl.ac.uk.
Funding
Medical Research Council MC_UU_00027/1
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19VaccinesAfricaHumansSARS-CoV-2Vaccines
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
NCT05525832ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.